AI-driven biomarker learning for the early diagnosis of neurodegenerative diseases: ABLEDx
Open Access
- 7 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Abstract
Tears are an easily accessible biofluid that reflects both emotional states and disease conditions. They are particularly enriched in extracellular vesicleKeywords
Funding Information
- Youth Science Fund Project (22474092)
- Shenzhen Science and Technology Innovation Commission (202323257)
This publication has 44 references indexed in Scilit:
- Autoencoders and their applications in machine learning: a surveyArtificial Intelligence Review, 2024
- Liquid Biopsy Proteomics in OphthalmologyJournal of Proteome Research, 2024
- A comprehensive review of the advances in neuromyelitis optica spectrum disorderAutoimmunity Reviews, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Hallmarks of neurodegenerative diseasesCell, 2023
- Potential application of heat shock proteins as therapeutic targets in Parkinson's diseaseNeurochemistry International, 2022
- Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensorsInternational Journal of Biological Macromolecules, 2021
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Neurology, 2019
- Why Only Humans Shed Emotional TearsHuman Nature, 2018
- Tears as a source of biomarkers for ocular and systemic diseasesExperimental Eye Research, 2013